Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × LY2784544 × Clear all

NCT01594723 2025-07-23

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms